Lilly Responds to COVID-19

In response to the crisis caused by COVID-19, Lilly is introducing the Lilly Insulin Value Program, allowing anyone with commercial insurance and those without insurance to fill their monthly prescription of Lilly insulin for $35. The program is effective today and covers most Lilly insulins. Details and more information can be found in the press release here:  

Please share information about this news with anyone who has trouble affording their insulin. Please consider sharing the following social media posts and images:

Lilly has introduced several solutions in recent years to help meet the individual financial circumstances of people living with diabetes that are still in effect during the COVID-19 crisis, including:

  • The Lilly Diabetes Solution Center, through which representatives can direct people to the $35 savings card, as well as affordability options that may reduce their out-of-pocket costs further – such as free insulin for people with minimal income, or no income at all, that has been donated by Lilly to non-profit organizations.
  • Three non-branded versions of our insulin options with list prices 50 percent lower than the branded versions.
  • In January, the company announced plans to donate at least 200,000 KwikPens® to relief agencies over the next three years.
Update About Lilly’s COVID-19 Efforts

Lilly announced the U.S. Food and Drug Administration has granted emergency use authorization for our neutralizing antibody as a treatment for recently diagnosed, mild to moderate COVID-19 in high-risk patients. This emergency authorization adds a valuable tool for doctors fighting the now-increasing burden of this global pandemic.

You can read more in our full press release, linked here. Please let me know if you have any questions or if I can provide additional educational resources.


The content and information contained on this site is being provided as a convenience and for informational purposes only. The posting of sponsored content on this site should not be considered an endorsement or recommendation of the sponsor's products, services, policies, or procedures by the American Association of Nurse Practitioners (AANP). The information and opinions expressed on this page are those of the paid sponsors and do not necessarily reflect the view of the AANP. AANP is not responsible for the content of third-party websites linked from this page; moreover, any links on this page to third-party websites where goods or services are advertised are not endorsements or recommendations by AANP of the third-party sites, goods, or services.